Charles Schwab Investment Management Inc Lexicon Pharmaceuticals, Inc. Transaction History

Charles Schwab Investment Management Inc

  • $521 Billion
  • Q1 2025

A detailed history of Charles Schwab Investment Management Inc transactions in Lexicon Pharmaceuticals, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 1,150,771 shares of LXRX stock, worth $805,539. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,150,771
Previous 1,191,091 3.39%
Holding current value
$805,539
Previous $881,000 39.95%
% of portfolio
0.0%
Previous 0.0%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 09, 2025
SELL
$0.29 - $0.96 $11,692 - $38,707
-40,320 Reduced 3.39%
1,150,771 $529,000
Q4 2024

Feb 06, 2025
SELL
$0.65 - $2.08 $147,032 - $470,504
-226,204 Reduced 15.96%
1,191,091 $881,000
Q3 2024

Nov 12, 2024
BUY
$1.51 - $2.39 $87,801 - $138,971
58,147 Added 4.28%
1,417,295 $2.23 Million
Q2 2024

Aug 12, 2024
BUY
$1.54 - $2.28 $736,158 - $1.09 Million
478,025 Added 54.25%
1,359,148 $2.28 Million
Q1 2024

May 08, 2024
BUY
$1.3 - $3.58 $22,032 - $60,673
16,948 Added 1.96%
881,123 $2.11 Million
Q4 2023

Feb 06, 2024
BUY
$1.0 - $1.53 $12,254 - $18,748
12,254 Added 1.44%
864,175 $1.32 Million
Q3 2023

Nov 08, 2023
BUY
$1.06 - $2.33 $147,918 - $325,142
139,546 Added 19.59%
851,921 $928,000
Q2 2023

Aug 09, 2023
BUY
$2.15 - $3.49 $51,092 - $82,936
23,764 Added 3.45%
712,375 $1.63 Million
Q1 2023

May 11, 2023
SELL
$1.99 - $2.68 $14,584 - $19,641
-7,329 Reduced 1.05%
688,611 $1.67 Million
Q4 2022

Feb 13, 2023
BUY
$1.8 - $2.56 $60,231 - $85,662
33,462 Added 5.05%
695,940 $1.33 Million
Q3 2022

Nov 14, 2022
BUY
$1.94 - $3.43 $442,153 - $781,745
227,914 Added 52.45%
662,478 $1.59 Million
Q2 2022

Aug 15, 2022
SELL
$1.31 - $2.69 $87,198 - $179,057
-66,564 Reduced 13.28%
434,564 $809,000
Q1 2022

May 13, 2022
BUY
$1.95 - $3.89 $24,784 - $49,441
12,710 Added 2.6%
501,128 $1.05 Million
Q4 2021

Feb 11, 2022
BUY
$3.81 - $6.16 $48,097 - $77,763
12,624 Added 2.65%
488,418 $1.93 Million
Q3 2021

Nov 16, 2021
BUY
$3.38 - $5.35 $20,584 - $32,581
6,090 Added 1.3%
475,794 $2.29 Million
Q2 2021

Aug 16, 2021
BUY
$4.12 - $5.87 $191,489 - $272,825
46,478 Added 10.98%
469,704 $2.16 Million
Q1 2021

May 17, 2021
BUY
$3.45 - $9.09 $308,568 - $813,009
89,440 Added 26.8%
423,226 $2.49 Million
Q4 2020

Feb 16, 2021
BUY
$1.05 - $3.67 $40,589 - $141,871
38,657 Added 13.1%
333,786 $1.14 Million
Q3 2020

Nov 13, 2020
BUY
$1.44 - $2.1 $16,178 - $23,593
11,235 Added 3.96%
295,129 $425,000
Q2 2020

Aug 14, 2020
BUY
$1.75 - $2.3 $30,101 - $39,562
17,201 Added 6.45%
283,894 $567,000
Q1 2020

May 15, 2020
BUY
$1.8 - $4.28 $6,917 - $16,448
3,843 Added 1.46%
266,693 $521,000
Q4 2019

Feb 07, 2020
BUY
$3.16 - $5.15 $99,347 - $161,910
31,439 Added 13.59%
262,850 $1.09 Million
Q3 2019

Nov 08, 2019
SELL
$1.2 - $6.66 $45,003 - $249,769
-37,503 Reduced 13.95%
231,411 $697,000
Q2 2019

Aug 09, 2019
BUY
$5.35 - $7.11 $19,709 - $26,193
3,684 Added 1.39%
268,914 $1.69 Million
Q1 2019

May 14, 2019
BUY
$4.36 - $7.94 $24,978 - $45,488
5,729 Added 2.21%
265,230 $1.48 Million
Q4 2018

Feb 14, 2019
SELL
$6.15 - $10.51 $41,475 - $70,879
-6,744 Reduced 2.53%
259,501 $1.72 Million
Q3 2018

Nov 13, 2018
BUY
$10.32 - $13.06 $259,898 - $328,903
25,184 Added 10.45%
266,245 $2.84 Million
Q2 2018

Aug 08, 2018
BUY
$7.8 - $13.69 $112,522 - $197,491
14,426 Added 6.37%
241,061 $2.89 Million
Q1 2018

May 07, 2018
BUY
$7.86 - $11.39 $55,633 - $80,618
7,078 Added 3.22%
226,635 $1.94 Million
Q4 2017

Jan 17, 2018
BUY
$8.77 - $12.28 $135,303 - $189,455
15,428 Added 7.56%
219,557 $2.17 Million
Q3 2017

Nov 13, 2017
BUY
$12.17 - $16.3 $2.48 Million - $3.33 Million
204,129
204,129 $2.51 Million

Others Institutions Holding LXRX

# of Institutions
134
Shares Held
196M
Call Options Held
310K
Put Options Held
77.3K
View Full List

About LEXICON PHARMACEUTICALS, INC.

LXRX Quotes by TradingView
  • Ticker LXRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 188,726,000
  • Market Cap $132M
  • Description
  • Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...
More about LXRX
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email